A carregar...
Autoimmunity, Checkpoint Inhibitor Therapy and Immune-related Adverse Events: A Review
Immune checkpoint inhibitors have emerged as a remarkable treatment option for diverse cancer types. However, a significant number of patients on checkpoint inhibitors develop immune-related adverse events (irAEs) affecting a wide variety of organs. These events, which may reflect enhanced T cell ac...
Na minha lista:
| Publicado no: | Semin Cancer Biol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6980444/ https://ncbi.nlm.nih.gov/pubmed/31330185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2019.06.012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|